Welcome to LookChem.com Sign In|Join Free
  • or
C110H118N6O24Si2 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1283092-79-4

Post Buying Request

1283092-79-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1283092-79-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1283092-79-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,8,3,0,9 and 2 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1283092-79:
(9*1)+(8*2)+(7*8)+(6*3)+(5*0)+(4*9)+(3*2)+(2*7)+(1*9)=164
164 % 10 = 4
So 1283092-79-4 is a valid CAS Registry Number.

1283092-79-4Downstream Products

1283092-79-4Relevant academic research and scientific papers

ANTIBACTERIAL AMINOGLYCOSIDE ANALOGS

-

Page/Page column 115, (2011/04/26)

Compounds having antibacterial activity are disclosed. The compounds have the following structure (I) including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q1, Q2, Q5, R1, R2, R3, Z1 and Z2 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.

ANTIBACTERIAL AMINOGLYCOSIDE ANALOGS

-

Page/Page column 83, (2011/04/26)

Compounds having antibacterial activity are disclosed. The compounds have the following structure (I): including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q1, Q2, R1, R2 and R3 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.

ANTIBACTERIAL AMINOGLYCOSIDE ANALOGS

-

Page/Page column 187, (2011/04/26)

Compounds having antibacterial activity are disclosed. The compounds have one of the following structures (I) or (II): including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q1, Q2, R1, R2, R3 and Z1 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1283092-79-4